The article focuses on the development of the Humanitarian Mechanism from the perspective of Médecins Sans Frontières (MSF). Topics mentioned include how the mechanism has facilitated access to more affordable pneumococcal conjugate vaccine (PCV), steps that could increase its potential for saving lives, and efforts of MSF to procure PCV for children in crises.